Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pfeffer

Showing results (501-510 of 908) with videos related to

Pageof 91
Sort By:
European Heart Journal. Acute Cardiovascular Care|February 23, 2021
Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction databaseSonya K Hui, Abhinav Sharma, Kieran Docherty, et al.
European Heart Journal|May 1, 1994
Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement StudyL A Moyé, M A Pfeffer, C C Wun, et al.
Circulation|January 1, 1994
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captoprilM St John Sutton, M A Pfeffer, T Plappert, et al.
Journal of the American College of Cardiology|October 18, 2003
Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE studyEldrin F Lewis, Lemuel A Moye, Jean L Rouleau, et al.
The New England Journal of Medicine|September 13, 1992
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsM A Pfeffer, E Braunwald, L A Moyé, et al.
European Journal of Heart Failure|July 22, 2022
Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failureMuthiah Vaduganathan, João Pedro Ferreira, Patrick Rossignol, et al.
Circulation. Heart Failure|October 18, 2015
Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of SpironolactoneAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
European Heart Journal|November 5, 2014
Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM programAli Vazir, Brian Claggett, Pardeep Jhund, et al.
Heart Rhythm|September 14, 2010
Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial--Cardiac Resynchronization Therapy (MADIT-CRT)Ilan Goldenberg, Arthur J Moss, Scott McNitt, et al.
Archives of Internal Medicine|November 10, 2004
Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunctionAlvaro M Murcia, Charles H Hennekens, Gervasio A Lamas, et al.
Pageof 91

Showing results (501-510 of 908) with videos related to

Sort By:
Pageof 91
European Heart Journal. Acute Cardiovascular Care|February 23, 2021
Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction databaseSonya K Hui, Abhinav Sharma, Kieran Docherty, et al.
European Heart Journal|May 1, 1994
Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement StudyL A Moyé, M A Pfeffer, C C Wun, et al.
Circulation|January 1, 1994
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captoprilM St John Sutton, M A Pfeffer, T Plappert, et al.
Journal of the American College of Cardiology|October 18, 2003
Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE studyEldrin F Lewis, Lemuel A Moye, Jean L Rouleau, et al.
The New England Journal of Medicine|September 13, 1992
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsM A Pfeffer, E Braunwald, L A Moyé, et al.
European Journal of Heart Failure|July 22, 2022
Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failureMuthiah Vaduganathan, João Pedro Ferreira, Patrick Rossignol, et al.
Circulation. Heart Failure|October 18, 2015
Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of SpironolactoneAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
European Heart Journal|November 5, 2014
Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM programAli Vazir, Brian Claggett, Pardeep Jhund, et al.
Heart Rhythm|September 14, 2010
Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial--Cardiac Resynchronization Therapy (MADIT-CRT)Ilan Goldenberg, Arthur J Moss, Scott McNitt, et al.
Archives of Internal Medicine|November 10, 2004
Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunctionAlvaro M Murcia, Charles H Hennekens, Gervasio A Lamas, et al.
Pageof 91